Arcion Therapeutics Inc赞助的临床试验
总计3103个结果
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics Inc招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, Inc终止IIIA 期非小细胞肺癌 | IIIB 期非小细胞肺癌 | 胰腺癌 | 头颈部鳞状细胞癌 | 复发性非小细胞肺癌 | IV 期非小细胞肺癌 | 转移性胰腺癌 | III期胰腺癌 | IV 期胰腺癌 | 复发性胆囊癌 | IV 期胆囊癌 | 不可切除的胆囊癌 | 不可切除的胰腺癌 | IIIA期胆囊癌 | IIIB期胆囊癌 | 不可切除的胆管癌美国
-
Hartford HospitalNational Institute of Mental Health (NIMH); Oui Therapeutics, Inc.完全的
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc终止
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc完全的
-
Jennifer WoyachKaryopharm Therapeutics Inc主动,不招人复发性成人弥漫性大细胞淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性小淋巴细胞淋巴瘤 | 幼淋巴细胞白血病 | 难治性慢性淋巴细胞白血病美国
-
SPR Therapeutics, Inc.United States Department of Defense; NDI Medical, LLC完全的
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer Center完全的复发性成人急性髓性白血病 | 成人急性巨核细胞白血病 (M7) | 成人急性微分化髓性白血病 (M0) | 成人急性单核细胞白血病 (M5a) | 成人急性单核细胞白血病 (M5b) | 成熟型成人急性成髓细胞白血病 (M2) | 未成熟的成人急性成髓细胞白血病 (M1) | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 成人急性粒单核细胞白血病 (M4) | 成人红白血病 (M6a) | 成人纯红细胞白血病 (M6b) | 未经治疗的成人急性髓性白血... 及其他条件美国
-
Bhavana BhatnagarKaryopharm Therapeutics Inc完全的急性髓性白血病 | 继发性急性髓性白血病 | 未经治疗的成人急性髓性白血病美国
-
VistaGen Therapeutics, Inc.National Institute on Drug Abuse (NIDA); Cato Research完全的
-
Therapeutic Advances in Childhood Leukemia Consortium完全的
-
Jina Pharmaceuticals Inc.Lambda Therapeutic Research Ltd.; Intas Pharmaceuticals, Ltd.招聘中
-
Therapeutic Advances in Childhood Leukemia Consortium招聘中淋巴瘤,B细胞 | 霍奇金淋巴瘤 | 淋巴母细胞淋巴瘤 | 淋巴瘤,T细胞 | 反洗钱 | 血液系统恶性肿瘤 | 材料数据表 | 急性未分化白血病 | 全部 | 混合表型急性白血病 | BPDCN美国, 澳大利亚
-
Therapeutic Advances in Childhood Leukemia Consortium终止
-
Therapeutic Advances in Childhood Leukemia Consortium终止
-
Mast Therapeutics, Inc.Worldwide Clinical Trials; Synteract, Inc.; Thywill Latam Solutions SRL; OCASA Soluciones Logísticas...完全的
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)招聘中
-
Ottawa Hospital Research InstituteOntario Institute for Cancer Research; Intensity Therapeutics, Inc.招聘中
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Candel Therapeutics, Inc.招聘中胶质瘤 | 胶质母细胞瘤 | 星形细胞瘤 | 脑恶性胶质瘤 | 脑癌 | 脑肿瘤 | 多形性胶质母细胞瘤 | 室管膜瘤 | 神经胶质瘤 | 少突神经胶质瘤 | 恶性星形细胞瘤 | 脑间变性少突胶质细胞瘤(诊断) | 混合寡聚星形细胞瘤 | 细胞性/核粘液样星形细胞瘤美国
-
Ki Health Partners. LLCRevance Therapeutics, Inc.; The Los Angeles Headache Center主动,不招人
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Affini-T Therapeutics, Inc.主动,不招人
-
Abide TherapeuticsCogState Ltd.; FGK Clinical Research GmbH; BASi (Bioanalytical Systems, Inc.)完全的
-
Jean Yuh TangVyne Therapeutics Inc.; Epidermolysis Bullosa Research Partnership完全的
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的
-
Massachusetts General HospitalAlkermes, Inc.; Otsuka America Pharmaceutical; Eisai Inc.; Janssen Pharmaceuticals; Sage Therapeutics 和其他合作者招聘中
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.招聘中
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH); Tvardi Therapeutics, Inc尚未招聘
-
Charles A. Czeisler, PhD, MDAxsome Therapeutics, Inc.招聘中
-
Canadian Cancer Trials GroupRoche Pharma AG; Janssen, LP; Karyopharm Therapeutics Inc招聘中
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的艾滋病病毒 | 有传染性的美国, 加拿大, 波多黎各
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的
-
Ki Health Partners. LLCRevance Therapeutics, Inc.; The Los Angeles Headache Center招聘中
-
Cancer Institute and Hospital, Chinese Academy...UTC Therapeutics Inc.尚未招聘间皮素阳性晚期恶性实体瘤
-
Fred Hutchinson Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb Company终止难治性 B 细胞非霍奇金淋巴瘤 | 复发性成人急性淋巴细胞白血病 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性成人急性淋巴细胞白血病 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 复发性转化非霍奇金淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 具有 MYC、BCL2 和 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性 B 型急性淋巴细胞白血病 | 复发性弥漫性大 B 细胞淋巴瘤,未另行说明 | 伴有 MYC 和 BCL2 或 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 难治性... 及其他条件美国
-
DICE Therapeutics, Inc., a wholly owned subsidiary...完全的
-
DICE Therapeutics, Inc., a wholly owned subsidiary...主动,不招人
-
Schmidhofer, Mark, MDCystic Fibrosis Foundation; Mast Therapeutics, Inc.主动,不招人
-
American Thrombosis and Hemostasis NetworkBayer; Shire; CSL Behring; Bioverativ Therapeutics Inc.完全的
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的
-
NovaDigm Therapeutics, Inc.United States Department of Defense; Cetero Research, San Antonio完全的
-
University of Colorado, DenverPediatric Epilepsy Research Foundation; West Therapuetics, Inc暂停
-
Therapeutic Advances in Childhood Leukemia ConsortiumAbbott终止
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizer完全的
-
Therapeutic Advances in Childhood Leukemia ConsortiumNovartis完全的
-
Melbourne HealthAnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical Research招聘中